Nadoxolol

{{Chembox

| ImageFile = Nadoxolol.svg

| ImageSize = 200px

| ImageAlt =

| IUPACName = {{prime|N}},3-Dihydroxy-4-naphthalen-1-yloxybutanimidamide

| OtherNames =

|Section1={{Chembox Identifiers

| CASNo = 54063-51-3

| CASNo_Ref = {{cascite|correct|CAS}}

| CASNo1 = 35991-93-6

| CASNo1_Ref = {{cascite|correct|CAS}}

| CASNo1_Comment = (hydrochloride)

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = SK43HU1689

| UNII1 = RZ9G589EN2

| UNII1_Ref = {{fdacite|correct|FDA}}

| PubChem = 6328253

| EINECS = 252-825-2

| ChemSpiderID = 4886543

| SMILES = C1=CC=C2C(=C1)C=CC=C2OCC(C/C(=N/O)/N)O

| InChI = 1/C14H16N2O3/c15-14(16-18)8-11(17)9-19-13-7-3-5-10-4-1-2-6-12(10)13/h1-7,11,17-18H,8-9H2,(H2,15,16)

| InChIKey = UPZVYDSBLFNMLK-UHFFFAOYAW

| StdInChI = 1S/C14H16N2O3/c15-14(16-18)8-11(17)9-19-13-7-3-5-10-4-1-2-6-12(10)13/h1-7,11,17-18H,8-9H2,(H2,15,16)

| StdInChIKey = UPZVYDSBLFNMLK-UHFFFAOYSA-N

| RTECS =

| MeSHName = C006154

}}

|Section2={{Chembox Properties

| C=14 | H=16 | N=2 | O=3

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility = }}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt = }}

}}

Nadoxolol is an antiarrhythmic agent (i.e., a drug for the treatment of irregular heartbeat),{{cite journal | last1 = Warembourg | first1 = H | last2 = Ducloux | first2 = G | year = 1976 | title = Clinical study of a new anti-arrhythmia agent: nadoxolol | journal = Lille Med. | volume = 21 | issue = 4| pages = 386–8 | pmid = 957857 }} chemically related in structure to beta-adrenergic receptor blocker drugs such as propranolol.{{cite journal|pmid=12818235|year=2003|last1=Kapoor|first1=M|last2=Anand|first2=N|last3=Koul|first3=S|last4=Chimni|first4=SS|last5=Manhas|first5=KS|last6=Raina|first6=C|last7=Parshad|first7=R|last8=Taneja|first8=SC|last9=Qazi|first9=GN|title=Kinetic resolution of 1-chloro-3-(1-naphthyloxy)-2-propanol, an intermediate in the synthesis of beta-adrenergic receptor blockers|volume=31|issue=3|pages=259–69|journal=Bioorganic Chemistry|doi=10.1016/s0045-2068(03)00050-6}}

It does not appear to be marketed anywhere in the world.